Adaptive Biotechnologies Corporation (ADPT)
NASDAQ · Healthcare
Adaptive Biotechnologies Corporation Cash on Hand 2017–2025
Adaptive Biotechnologies Corporation annual cash on hand history from 2018 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Adaptive Biotechnologies Corporation cash on hand as of December 31, 2025: 70.5M, a 47.11% increase year-over-year.
- Adaptive Biotechnologies Corporation cash on hand for 2025 were 70.5M, a 47.11% increase from 2024.
- Adaptive Biotechnologies Corporation cash on hand for 2024 were 47.9M, a 26.35% decrease from 2023.
- Adaptive Biotechnologies Corporation cash on hand for 2023 were 65.1M, a 27.73% decrease from 2022.
- Adaptive Biotechnologies Corporation cash on hand for 2022 were 90.0M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Adaptive Biotechnologies Corporation Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $70 |
| 2024 | $48 |
| 2023 | $65 |
| 2022 | $90 |
| 2021 | $139 |
| 2020 | $123 |
| 2019 | $97 |
| 2018 | $55 |
Adaptive Biotechnologies Corporation Cash on Hand — FAQ
Adaptive Biotechnologies Corporation (ADPT) cash on hand over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADPT's cash on hand history?
The chart and table above show Adaptive Biotechnologies Corporation's cash on hand by year and by quarter, including the growth rate.